Glimepiride/Metformin Hydrochloride

ๆ ผๅˆ—็พŽ่„ฒ/็›้…ธไบŒ็”ฒๅŒ่ƒ

Report date: 2022/01/14 13:23:58

Base Information

Drug NameGlimepiride/Metformin Hydrochloride
Drug Alias NameMetformin Hydrochloride and Glimepirideๆ ผๅˆ—็พŽ่„ฒ็›้…ธไบŒ็”ฒๅŒ่ƒMetformin Hydrochloride/Glimepiride็›้…ธไบŒ็”ฒๅŒ่ƒ/ๆ ผๅˆ—็พŽ่„ฒ็›้…ธไบŒ็”ฒๅŒ่ƒๆ ผๅˆ—็พŽ่„ฒ +[13]ย 
ClassificationSmall molecules
Mechanisms of ActionKATP channels blockersProtein kinase AMP-activated non-catalytic subunit beta 1 activatorsSulfonylurea receptor modulators
TargetsSulfonylurea receptorProtein kinase AMP-activated non-catalytic subunit beta 1KATP channels
Therapy Area/IndicationsDiabetes Mellitus, Type 2
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Metformin HydrochlorideGlimepiride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesSanofi
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2
Inactive IndicationsN/A

Other Information

ATC CodeA10BD
Related LinksN/A